Pneumocystis carinii is an opportunistic pathogen which can produce a fatal pneumonia in immunocompromised individuals (15) . The increased number of cases of P. carinii pneumonia associated with acquired immunodeficiency syndrome (5) has attracted the interest of many scientists and has promoted studies for developing noninvasive laboratory tests for diagnosing the disease. However, none of the current assays being tested appear to be useful in the diagnosis of P. carinii pneumonia which, in part, may be because of the reagents available to perform the assays (10, 11, 12) . An improved assay with specific reagents is needed to assist in the diagnosis of P. carinii pneumonia and to differentiate between clinical and subclinical infections.
The fact that monoclonal antibodies are highly homogeneous and can be produced in potentially unlimited amounts often gives them advantages over polyclonal antibodies in the development of diagnostic reagents and in the study of antigenic components of organisms (2, 18, 19) . With this in mind, we set out to develop a series of monoclonal antibodies to P. carinii. In this communication, we describe the production and characterization of 12 murine monoclonal anti-P. carinii antibodies by the technique of Kohler and Milstein (7) . In addition, we present some data on the identification of a major P. carinii antigen by Western blotting techniques.
MATERIALS AND METHODS
P. carinii isolation. P. carinii was obtained from the lungs of adult male Sprague-Dawley rats (weighing 200 to 250 g) given a cortisone acetate and low protein diet regimen as described by Walzer et al. (22) 63 ). Briefly, the lung digestion procedure was as described but with the addition of 10 mM 2-naphthol-6,8-disulfonic acid and 0.4% (wtlvol) beef pancreas DNase (Sigma Chemical Co., St. Louis, Mo.) to the digestion mixture. Biphasic Percoll (Pharmacia) gradients, with densities of 1.033 and 1.045 g/ml, were used instead of Ficoll gradients as the media to separate P. carinii organisms from the lung debris. Gradients were centrifuged at 400 x g for 30 min in a rotor (HB4; Ivan Sorvall, Inc., Norwalk, Conn.). The majority of the cysts and trophozoites were found at the 1.033-and 1.045-g/ml interface of the gradient and were separated from host lung material which was pelleted at the bottom of the tube. The cyst-and trophozoite-containing fraction was removed, diluted 5:1 in buffer, and washed several times at 13 ,000 x g for 15 min in Hanks balanced salt solution with Ca and Mg. Aliquots of the fraction were stained with toluidine blue, and cyst counts were made by using the method of Ikai et al. (4) .
Antigen preparations. (i) Whole antigen. The P. carinii material, obtained from the Percoll gradient and referred to as the P. carinii whole digest (PCDW), was used for immunization of mice for subsequent hybridoma production, for the indirect immunofluorescence assays (IIFAs), and for the Western immunoblotting studies. For Western immunoblotting experiments, PCDW was solubilized with 1% sodium dodecyl sulfate (SDS) before running on polyacrylamide gels.
(ii) Soluble Production of hybridomas and isotyping of clones. Optimal conditions for cell fusion in the laboratory have been established. Briefly, spleen cells were removed aseptically from the mice and were minced through sterilized 100-mesh screen. The mincings were washed in Iscove modified Dulbecco medium (GIBCO Laboratories, Grand Island, N.Y.) containing 20% horse serum (IMDM-20) HyClone Laboratories, Logan, Utah) and gentamicin sulfate (50 jig/ml). Spleen cells were centrifuged at 400 x g for 7 min, and the supernatant was decanted. The cells were resuspended in IMDM-20, and cell counts were made by using trypan blue exclusion to determine viable cell numbers. Murine myeloma cells (P3X63-Ag8.653), a variant of the original P3X63-Ag8 cell line (6) with greater than 95% viability, were mixed with equal numbers of splenic lymphocytes (usually 3 x 107 cells). A cell ratio of 1:1 (spleen cells to myeloma cells) was used in these studies instead of larger ratios of 5:1 or 2:1, since this ratio gave us excellent fusion efficiencies in earlier fusion experiments in our laboratory. The mixed cells were centrifuged at 400 x g for 7 min, the supernatant was decanted, and 3 ml of a 35% solution of sterile polyethylene glycol (pH 7.8) was added. The pellet was gently shaken and then was left undisturbed for 6 min at 30°C, after which time it was centrifuged and resuspended in IMDM-20. The cells were then washed by centrifugation at 900 x g for 5 min and were resuspended carefully in IMDM-20, avoiding harsh disruption of the cell pellet. The cells were incubated in a 75-cm2 tissue culture flask for 24 to 48 h at 37°C in a 6% CO2 atmosphere. After this incubation, the cells were centrifuged, suspended in HAT medium (IMDM-20 containing 10-4 M hypoxanthine, 4 x 10-7 M aminopterin, and 1.6 x 10-5 M thymidine), and plated into 96-well microtiter (Nunc) plates. The cells were fed HAT medium (50% volume) every 2 days. When growth of hybrids was detected microscopically (usually at 10 to 14 days), supernatant culture fluid was removed and assayed for antibody activity by using the ELISA. Cells from antibodypositive wells were transferred to 24-well Nunc plates in HAT medium and then were subcloned by using the soft agar method (3) . Colonies appeared in the soft agar after approximately 2 weeks, at which time 20 individual colonies were picked and placed into 96-well plates. Once these subclones started to grow, culture fluids were assayed for antibody activity by using the ELISA. Two or three of the subclones found to be strongly positive for antibody production were cloned once more to assure monoclonality. The hybrid clones were then either expanded to larger cultures, frozen at -70°C, or inoculated into mice for ascites production.
To obtain large amounts of antibody, clones of hybrid cells were injected intraperitoneally into BALB/c mice which had been primed 2 or more weeks earlier with 0.5 ml of pristane (2,6,10,14-tetramethylpentadecane) (Sigma). Animals were observed daily, and ascitic fluids were collected when formed (usually 8 to 12 days after injection).
Isotyping of the monoclonal antibodies was done by using the Ouchterlony double diffusion test as previously described (3). Monoclonal immunoglobulins were concentrated 20-fold by salt fractionation (50% saturation by using ammonium sulfate) of the hybridoma culture supernatant and were placed in the outside wells of an Ouchterlony plate. The center wells contained goat anti-mouse antibody specific to either immunoglobulin Gl (IgGl), IgG2a, IgG2b, IgGA, or IgM (Meloy Laboratories, Inc., Springfield, Va.). Monoclonal antibodies to be isotyped were placed in wells that surrounded the center well.
ELISA for detection of P. carinii-specific antibodies. The indirect ELISA for antibody determinations (21) was performed by using disposable Nunc Immunoplate I polystyrene 96-well microtiter plates as the solid phase. The PCDS or NRL antigen was appropriately diluted in carbonatebicarbonate coating buffer (0.015 M Na2CO3, 0.035 M NaHCO3, 0.003 M NaN3, pH 9.6), and 200 ,ul of antigen per well (2.5 ,xg/ml) was bound to the solid phase by incubation at 37°C for 2 h in a humid chamber, followed by storage at 4°C in an airtight container until used. The PCDS was used instead of the PCDW, since the ELISA was being used to detect antibodies (monoclonal and polyclonal) against all P. carinii antigens, not just antigens on the surface of the whole organism (PCDW). When the antigen-coated plates were used, the wells were emptied by shaking, and each well was washed three times in PBS-Tween 20 buffer (0.136 M NaCl, 0.001 M KH2PO4, 0.02 M Na2HPO4, 0.003 M KCl, 0.05% Tween 20, 0.003 M NaN3). Unbound sites on the microtiter plates were reacted with 50 ,u of 0.5% porcine serum albumin per well diluted in PBS-Tween 20 buffer for 1 h at 25°C in a humid chamber. The 0.5% porcine serum albumin solution was removed from the plates by shaking, and the plates were washed twice with the PBS-Tween 20 buffer. Sera or culture fluids to be tested were appropriately diluted in PBS-Tween 20 buffer, and 50 RI of the solution per well was added to the plates. Culture fluids from the original fused hybrid cells were screened for antibody activity undiluted. Plates were incubated at room temperature for 2 h in a humid chamber. The plates were then shaken dry and washed four times with the PBS-Tween 20 buffer. Goat anti-mouse immunoglobulins (IgGl, IgM, and IgA) conjugated with alkaline phosphatase (Sigma) were added (50 ,u per well; 1:750 dilution in PBS-Tween 20 buffer, pH 7.6), and the plates were incubated for 2 h more at room temperature on a shaker. The conjugate was then discarded, plates were washed four times with PBS-Tween 20 buffer, and freshly prepared p-nitrophenyl phosphate substrate solution (1 mg of p-nitrophenyl phosphate per ml of diethanolamine buffer; 97 ml of diethanolamine per liter plus 0.497 M MgCl2 and 0.003 M NaN3, pH 9.8) was added (50 ,u of solution per well). The plates were incubated at room temperature for 30 min with shaking. The reaction was stopped by adding 50 ,u of quencher (0.5 M Na2CO3) per well, and optical density was measured at 405 nm with an enzyme immunoassay reader (Bio-Tek Instruments, Inc., Shelburne, Vt.). Positive and negative mouse serum controls (diluted 1:100), conjugate control (antigen on plate with no antibody added), and both P. carinii-and NRL-sensitized target plates were tested in parallel in all ELISA determinations when testing hybrid cells for antibody production. Hybrid cells were considered positive for antibody production to P. carinii only if an A405 in the ELISA, by using PCDS as test antigen, was at least three times that obtained with NRL as test antigen. An activity differential (an absorbance for PCDS versus an absorbance for NRL) of 1.0 or greater optical density units at 405 nm (i.e., 1.5 versus 0.5) was used to select positive antibody-producing hybrid cells for further characterization. This criterion was established, since the NRL preparation initially obtained from normal Sprague-Dawley rats and used for the ELISA was found to contain low numbers of cysts.
A positive antibody titer of any given serum or culture fluid containing the monoclonal antibodies was defined as the reciprocal of the dilution which had a mean optical density of 0.2 U above the mean optical density of the negative control wells containing predisease, preimmunization, or normal serum as the primary antibody.
Cross-reactivity of monoclonal antibodies. Determinations of cross-reactions of the monoclonal antibodies with several bacteria and fungi known to cause infections in immunosuppressed individuals were made. Monoclonal antibodies were absorbed with various bacteria and fungi and then were reacted in the standard P. carinii ELISA. All organisms were isolated from clinical samples and were killed with Merthiolate before use. Suspensions of killed organisms were made in PBS, and the densities of the suspensions were adjusted with a spectrophotometer to give an optical density reading of 0.3 units at 650 nm. Preparations of whole P.
carinii organisms were also used in this study. Ascitic fluids (diluted from 1:2,000 to 1:16,000 to give an absorbanpe value in the P. carinii ELISA of approximately 1.0) were added to the various preparations that had been pelleted (2,000 x g for 5 min). A positive control, polyclonal rat sera no. 3.1 (pool of sera obtained from several rats after recovery from P. carinii infection that had an ELISA titer of 1:3,200) , and a negative control, normal ascitic fluid, both diluted 1:200, were also used. The pellets were then suspended again, and the mixtures were incubated for 3 h at room temperature and then overnight at 4°C. After this absorption period, the mixtures were centrifuged at 2,000 x g for 5 min, and the supernatant fluids were reacted in the standard P. carinji ELISA described previously.
IIFA. Suspensions containing approximately 5 x 104 whole cysts per 10 ,ul were placed on 12-well immunofluorescence slides and allowed to air dry for 3 h. After 10 RI of twofold serial dilutions (1:40 to 1:20,480) of ascitic fluids were placed on the wells of the slides, the slides were incubated for 1 h in a moist chamber at 25°C. The slides were then washed three times with PBS and once with distilled water. The monoclonal antibodies were detected by an unfractionated sheep anti-mouse immunoglobulin antibody labeled with fluorescein isothiocyanate (Sigma) at a 1:20 dilution in 1:500 Evans blue dye. The dilution of labeled sheep anti-mouse immunoglobulin antibody was arrived at by preliminary tests that determined the lowest dilution that failed to fluoresce with P. carinii untreated with monoclonal antibody. The dilution was found to be 1:20. After incubation for 1 h at 25°C in a moist chamber, the slides were washed three times with PBS, air dried, covered with buffered glycerol (pH 9.0), and examined with a fluorescence microscope (Olympus Corp. of America, New Hyde Park, N.Y.). Controls included wells with P. carinii that were overlayered with either PBS buffer or a nonspecific monoclonal antibody (against bovine leukemia virus) before overlayering with a 1:20 dilution of labeled sheep anti-mouse immunoglobulin antibody. Under these conditions, these controls were consistently negative.
Immunoblotting procedure. PCDW and NRL preparations were solubilized with a sample buffer (0.1% SDS, 1.25% 2-mercaptoethanol, 0.02% bromophenol blue, 0.02 M Tris hydrochloride, and 7% glycerol, pH 6.8) for 3 min at 100°C. Antigen samples containing 2.5 gxg of protein were electrophoresed through 5 to 15% polyacrylamide gradient gels in a discontinuous buffer system described by Laemmli (8) . Electrophoresis was performed at 15 mA per gel until the ion front reached the bottom of the gel. This was usually 4.5 h. Molecular weight protein standards were included in each run. Immunoblotting of the gels was performed by a method similar to that of Towbin et al. (20) . Briefly, the proteins were electrophoretically transferred to nitrocellulose paper (0.45-,um pore size) at 80 mA for at least 16 h. A portion of the membrane containing the molecular weight standards, and one lane each of P. carinii and NRL digest was stained with amido black (0.2 g of amido black in a mixture of 90 ml of methanol, 20 ml of acetic acid, and 80 ml of distilled water). The other portion of the membrane was incubated with 1% Tween 20 in PBS for 1 h at 37°C. The sheets were subsequently incubated for 2 h at room temperature with either positive rat infection-derived P. carinii serum (diluted 1:100 in PBS-Tween 20 buffer) or with culture fluids containing various monoclonal antibodies, followed by four washes in PBS-Tween 20 buffer over a period of 30 min. Positive P. carinii serum was harvested from rats that had recovered from pneumocystosis and was designated as infectionderived rat serum. The ELISA antibody titer of the pool was VOL. 51, 1986 1:3,200. The membranes were then incubated for 1 h with peroxidase-conjugated goat anti-mouse IgG (obtained from V. Tsang, Centers for Disease Control, Atlanta, Ga.) or anti-rat IgG (Sigma) that had been diluted 1:1,000 in PBSTween 20 buffer. This was followed by five washes in PBS-Tween 20 buffer. Finally, the antigenic bands were developed by the addition of 4-chloro-1-naphthol and H202. The substrate solution was made by adding 25 mg of 4-chloro-1-naphthol to 0.5 ml of 95% ehtanol. After the substrate was dissolved in ethanol, the mixture was added to 100 ml of 0.05 M Tris buffer (pH 7.4) and was allowed to stir in the dark for 30 min. The substrate solution was then filtered and used immediately after addition of 17 ,ul of 30% H202. Antigenic reactive bands stained a deep purple color in 3 to 5 min. Blots were rinsed in distilled water and photographed.
Initially, PCDS was used instead of PCDW for polyacrylamide gel electrophoresis and Western immunoblotting analysis. By using either preparation, the major antigenic band was detectable with monoclonal antibodies. However, the PCDS antigen preparation gave a large amount of background activity on the blots, making visualization of the reactive antigens somewhat difficult. This background activity (smearing) was assumed to be caused by the breakdown of P. carinii antigens into small fragments by sonication. These many fragments would then migrate through the gel, giving a smeared appearance when reacted with specific antibodies. Thus, to eliminate the smearing effect, PDCW was used for polyacrylamide gel electrophoresis and Western immunoblotting analysis instead of PCDS.
Competitive binding assays. The solid-phase antibody binding assay (17) was conducted by using PCDS antigen bound to wells (2.5 ,ug of antigen per well) of breakaway microtiter plates (Dynatech Laboratories, Inc., Alexandria, Va.). Antigen was bound to the microtiter plates, and unbound sites were blocked with 1.0% bovine serum albumin or 0.5% porcine serum albumin as described previously for the ELISA. Saturating amounts (50 ,u) of a first (inhibitory) monoclonal antibody that had ben concentrated 10-fold from culture fluids of the hybridoma cells were added to each well, and the plates were incubated overnight at 4°C. Radiolabeled antibody (10 RI; 450 to 7,500 cpm) was then added to the appropriate wells, and the reaction mixture was incubated at room temperature for 3 h with shaking. After the 3-h incubation, the plates were extensively washed as described previously for the ELISA, and the bound radioactivity was determined by separating the individual wells, placing them in a toluene-based scintillation cocktail, and counting them in a liquid scintillation spectrometer. Biosynthetic labeling of monoclonal antibodies was done by cultivating the hybridoma cells (106 cells per ml of medium) for 48 h at 37°C in leucine-free medium (RPMI 1640 minus leucine; Gibco) supplemented with 10% dialyzed horse serum and 20 ,uCi of [3H]leucine (New England Nuclear Corp., Boston, Mass.) per ml of serum. RESULTS Isolation of hybrid cell lines producing anti-P. carinii antibodies. Hybridization was performed by fusion of P3X63-Ag8.653 myeloma cells with splenic lymphocytes from BALB/c mice immunized with 2 partially purified preparation of P. carinii. We seeded 24 microtiter plates (2.5 x 10' cells per well) from three fusions. Fusion efficiency (the number of wells showing hybrid cell growth out of a total number of wells seeded) was about 75% for the three fusions. All of the culture fluids from the wells showing cell growth were tested by ELISA for antibodies against P. carinii. Hybrid cells were considered positive for antibody production to P. carinii if an optical density reading at 405 nm on the ELISA (using PCDS as test antigen) was at least three times that obtained when using NRL as test antigen. We found that 227 hybrid clones (polyclones) were producing immunoglobulins to P. carinii. These cultures were expanded to larger culture dishes and reassayed for activity, and those showing high activity were frozen at -70°C. Of these cultures which had an antibody reactivity differential (absorbance for PCDS versus absorbance for NRL) of 1.0 or greater in the ELISA (Table 1) , 12 were cloned twice in soft agar. This process resulted in teh isolation of 12 stable cloned cell lines which were producing monoclonal antibodies at a significant level. Monoclonal antibodies produced in the first fusion were given T numbers, and those from the last two fusions were given C numbers.
Serological characterization of the anti-P. carinii monoclonal antibodies. The isotypes of the 12 monoclonal antibodies were determined by Ouchterlony double diffusion by using monospecific polyclonal goat antibodies against the different murine immunoglobulin isotypes. Of the monoclonal antibodies (T-17 and T-36), 2 were of the IgG2b isotype, whereas the remaining 10 monoclonal antibodies were of the IgGl isotype (Table 2) . Because we wanted highly reactive antibodies which would be useful in a wide variety of assays, titers of the 12 monoclonal antibodies were determined by using the ELISA and the IIFA. Results indicate that titers of the monoclonal antibodies in ascitic fluids ranged from 1:8,000 to 1:64,000 in the ELISA and from 1:40 to 1:10,240 for the IIFA ( hybrid clone into pristane-primed mice were 10-to 100-fold higher than titers of the culture supernatant fluids. In the IIFA, the P. carinii cysts stained brightly in the typical peripheral rim pattern that has been shown in earlier studies by using polyclonal antiserum (13; personal observation). Monoclonal antibody against another antigen (bovine leukemia virus) did not react with P. carinii. Cross-reactivities of the established monoclonal antibodies were evaluated by using several organisms capable of causing infections in an immunosuppressed host ( (Table 4) . Antibodies C-272, C-360, T-123, and T-53 effectively competed ('80%) with each other and, to a lesser extent, with the other monoclonal antibodies. Therefore, they appear to be directed against the same epitope or against antigenic determinants located close to each other. Similarly, C-234 and T-34 form one group, and C-275 and T-275 form another group recognizing the same epitope or an antigenic determinant in the same region, respectively. With monoclonal antibodies T-17, T-84, C-299, and T-36, significant competition was demonstrated only with homologous unlabeled antibody. These 12 monoclonal antibodies were then divided into 7 groups, each group reacting with specific antigenic determinants or with a specific region with closely situated antigenic determinants on P. carinii antigens. These are groups A
(C-272, C-360, T-123, T-23), B (C-234, T-34), C (C-275, T-275), D (T-17), E (T-84), F (C-299), and G (T-36).
Identification of P. carinii-reactive antigens with the 12 monoclonal antibodies. The Western immunoblotting technique (19) was used to identify P. carinii-specific molecules which had specific antigenic reactivity for the 12 monoclonal antibodies (Fig. 1) T-17  T-84  C-272  C-360  T-123  T-53  C-299  C-234  T-34  C-275  T-275  T-36  antibody   T-17  93  61  74   80  71  70  61  30  40  58  51  40   T-84  <5  84  <5  35  <5  <5  69  23  34  28  13  49   C-272   47  26  88  90  88  92  <5  <5  <5  30  23  17   C-360  52  8  88  94  92  95  57  27  37  33  12  47  T-123  40  <5  80  75  87  81  <5  <5  39  10  <5  45  T-53  38   <5  75  77  87  89  40  12  40  13  <5  48   C-299  52  16  23  34  25  38  97  55  56  54  46  72  C-234   54  64  34  42  31  39  56  88  92  79  75 monoclonal antibodies reacted with a major polypeptide of P. carinii in the 110,000-molecular-weight region. Other minor polypeptides, with molecular weights of approximately 116,000, 90,000, 55,000, and 35,000, were recognized by most of the monoclonal antibodies. Infection-derived rat serum also reacted with the 110,000-molecular-weight polypeptide when analyzed by the Western blot technique (Fig.  1, lane 8) . In addition, it reacted with several molecules in the 35,000-to 55,000-molecular-weight region. Two polypeptide bands in the approximately 14,000-to 16,000-molecularweight region were detected in germ free rat lung tissue preparation with most of the monoclonal antibodies. Germfree rat serum (Charles River Breeding Laboratories, Inc., Wilmington, Mass.) or goat anti-mouse or anti-rat IgG conjugated to horseradish peroxidase did not bind to any of the polypeptide bands, thus giving support to the conclusion that the monoclonal antibodies recognize P. carinii polypeptides. DISCUSSION The primary purpose of this study was to develop and characterize a panel of monoclonal antibodies against P. carinii. The antibodies with greatest specificity, stability, and binding activities could then potentially be used to develop a highly sensitive double-antibody ELISA for antigen detection and to aid in the analysis of the antigenic components of P. carinii by Western immunoblot techniques. Of murine hybrid cell lines, 227 were successfully developed which secrete antibody that reacts with P. carinii. This high percentage of positive clones indicates that mice respond well to P. carinii. Of these hybridomas, 12 (C-234, C-272, C-275, C-299, C-360, T-17, T-34, T-36, T-53, T-84, T-123, and T-275) were cloned and characterized. All 12 monoclonal antibodies produced by these hybridomas were preferentially reactive with one major P. carinii antigen (molecular weight, 110,000), suggesting that this molecule is a source of immunodominant components. Studies are in progress to determine what P. carinii antigens are detected by the other 227 hybridomas secreting monoclonal antibodies.
With the competitive binding inhibition assay, using fixed amounts of P. carinii antigen on the microtiter plates, saturating amount of cold homologous and heterologous antibody, and known amounts of radiolabeled competing antibody, the epitope specificities of the different monoclonal antibodies were divided tentatively into 7 groups. Each group reacted with different epitopes or regions containing antigenic determinants closely related as to cause-binding interference. They are groups A (C-272, C-360, T-123, and T-53), B (C-234 and T-34), C (C-275 and C-272), D (T-17), E (T-84), F (C-299), and G (T-36). These data may be extremely valuable when monoclonal antibodies are chosen for use in a serodiagnostic assay. Use of antibodies directed against different epitopic groups should enhance the specificity and sensitivity of the assay.
The hybridomas selected in this study provided a constant source of antibodies, which have been shown to be active reagents in the indirect ELISA, with their titers ranging from 1:8,000 to 1:64,000. In addition, a majority of them were reactive in the IIFA, staining whole P. carinii cells brightly. A typical rim pattern of fluorescence was observed (data not shown) similar to that seen by Milder et al. (13) with polyclonal serum. The IIFA titer ranged from 1:40 to 1:10,240. The low level of reactivity of monoclonal antibodies C-234 and C-299 with whole intact P. carinii cells could possibly be caused by the inaccessibility of the antigenic determinants to these antibodies. Their reactivity in the ELISA, where the organisms are used disrupted, was quite good, with their titers being 1:16,000 and 1:32,000, respectively. These observations, together with the demonstration of the absence of competition with the other monoclonal antibodies (except C-234 with T-34, whose IIFA titer was not determined) in the competition assay, suggest that C-234 and C-299 probably recognize different epitopes which are masked on the surface of the organisms. More precise studies are needed to ascertain what cellular component the antibodies react against.
The monoclonal antibodies were tested for crossreactivity with Candida albicans, Cryptococcus neoformans, M. avium, and H. capsulatum in an absorption experiment (Table 3) . Cross-reactivity was observed with one monoclonal antibody, T-17. This monoclonal antibody has been shown to have a strong binding avidity (unpublished data), and this may account for the cross-reactivity. Because of its nonspecific reactivity, this monoclonal antibody will not be used in our studies attempting to develop an antigenemia assay. In addition, T-53 will not be used, since in the absorption experiment (Table 3) antibody reactivity was absorbed with P. carinii. It is not fully understood why T-53 had such a high IIFA titer (Table   2 ) and yet was not effectively absorbed with P. carinii.
Possibly, the antigens of P. carinii are presented in such a way in the IIFA procedure that they make them more accessible to T-53. The fact that the other 10 monoclonal reagents have high specificity for P. carinii and did not react with other opportunistic organisms that could potentially infect the lungs of immunosuppressed hosts encourages further exploration of their use in developing diagnostic assays for human P. carinii infections.
Polyacrylamide gel electrophoresis of P. carinii, followed by Western immunoblotting analysis, enabled determination of the monoclonal antibody reaction with P. carinii antigenic components. All 12 monoclonal antibodies reacted with a major antigenic component of P. carinii in the 110,000-molecular-weight region (Fig. 1A and B) . Other The reaction of many of the monoclonal antibodies with low-molecular-weight (14,000 and 16,000) molecules in the germfree rat preparations was assumed to be nonspecific.
We were unable to demonstrate the presence of P. carinii cysts in the lungs of our germfree rats. We conclude that either these animals were completely free of P. carinii, or the number of organisms (cysts and trophozoites) was very low and undetectable by lung touch preparations and lung digests. However, since it has been reported by Pifer et al. (16) that certain germfree rats contain P. carinii, future studies are needed to determine the specificity of these reactions.
Our monoclonal antibodies recognized more than one molecule when analyzed by Western immunoblotting. Similar findings have been reported for monoclonal antibodies against Trypanosoma cruzi (14) . Several hypotheses may explain these results. One possible explanation involves multiple antigenic determinants (maybe CHO) on several molecules of different molecular weights. A second possibility involves the manner in which the P. carinii antigen preparation is processed before analysis by Western blotting. The harsh procedure of using SDS and 2-mercaptoethanol may cleave larger precursor molecules. When 2-mercaptoethanol was not used, a large molecule with a molecular weight of >200,000 was recognized by the monoclonal antibodies (unpublished data). A similar molecule was observed by Maddison et al. (9) when P. carinii from rats was analyzed with SDS polyacrylamide gel electrophoresis in the absence of 2-mercaptoethanol. Thus, it appears that the molecular weight of a major antigen molecule found in PCDW is >200,000 and that the 110,000-molecular-weight band and maybe some of the lesser bands are products of the 2-mercaptoethanol treatment. We cannot exclude the possibility that these reactive antigens are, in part, the results of proteolytic or other enzymatic degradation during the P. carinii separation from infected lung tissue. However, if this was the case, it seems that the size of the antigenic molecules would vary from one preparation to the next, but this has not happened. A third possibility is that these different antigenic molecules are the consequence of a natural processing of molecules occurring inside the parasite during different developmental stages.
In summary, we isolated a series of hybridomas which produced monoclonal antibodies to P. carinii. We cloned 12 of these hybridomas which produced antibody in high quantities and were specific for a component of P. carinii that has a molecular weight of approximately 110,000. The unique qualities of 10 of these monoclonal antibodies make them potentially excellent reagents for a serodiagnostic assay. Since one goal of our laboratory is to develop a sensitive assay which could be used to detect low levels of P. carinji antigen in clinical samples of biological fluids, these antibodies are being tested separately and in various combinations for their effectiveness in an antigenemia assay (modified ELISA) by using the rat model. Various combinations of monoclonal antibodies are being tested, since one possible disadvantage of a monoclonal antibody is that it is too specific and detects only one specific antigen although other antigens may be relevant for diagnosis. In addition, work is in progress to analyze further the monoclonal antibodies produced by the other 227 hybridomas originally isolated in our laboratory. If any of these are found to be specific for P. carinii antigens other than the 110,000-molecular-weight component, they will be characterized and tested in our modified antigenemia assay. Further studies are needed to determine whether the existing monoclonal antibodies would be sufficiently cross-reactive with P. carinii isolated from humans to be usable in serodiagnostic studies of clinical specimens from humans. These monoclonal antibodies may be very useful in demonstrating antigenic differences that may exist (2, 24) between P. carinii of humans, of rats, and of other species, as well as potential antigenic differences in different stages of the life cycle (e.g., cyst, trophozoite, and intermediate stages).
